Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction

Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of actio...

Full description

Saved in:
Bibliographic Details
Main Author: Doshi, Sanjay Lalitchandra
Format: Thesis
Language:en
Published: 2001
Subjects:
Online Access:http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf
http://eprints.usm.my/36699/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1834501033224568832
author Doshi, Sanjay Lalitchandra
author_facet Doshi, Sanjay Lalitchandra
author_sort Doshi, Sanjay Lalitchandra
building Hamzah Sendut Library
collection Institutional Repository
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
continent Asia
country Malaysia
description Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of action and need for higher dosage in diabetic patients with erectile dysfunction when compared to the general population. No study targeted specifically to the diabetic population has been completed with Alprostadil so far.
format Thesis
id my.usm.eprints.36699
institution Universiti Sains Malaysia
language en
publishDate 2001
record_format eprints
spelling my.usm.eprints.36699 http://eprints.usm.my/36699/ Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction Doshi, Sanjay Lalitchandra RC31-1245 Internal medicine Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of action and need for higher dosage in diabetic patients with erectile dysfunction when compared to the general population. No study targeted specifically to the diabetic population has been completed with Alprostadil so far. 2001 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf Doshi, Sanjay Lalitchandra (2001) Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction. Masters thesis, Universiti Sains Malaysia.
spellingShingle RC31-1245 Internal medicine
Doshi, Sanjay Lalitchandra
Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_full Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_fullStr Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_full_unstemmed Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_short Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
title_sort efficacy and safety of intracavernosal alprostadil in diabetic patients with erectile dysfunction
topic RC31-1245 Internal medicine
url http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf
http://eprints.usm.my/36699/
url_provider http://eprints.usm.my/